Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hepatitis

Free Subscription 27.01.2025 1 Gastroenterol Hepatol 2 Hepatology 1 J Hepatol 4 J Viral Hepat 1 J Virol 1 PLoS One 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Gastroenterol Hepatol

1. LUIS CASTRO URDA J, Alvarez M, Cantero H, Ayala V, et al
   The efficiency of artificial intelligence for management and clinical decision-making in the identification of patients with undiagnosed HCV infection (Intelligen-C strategy).
   Gastroenterol Hepatol. 2025 Jan 18:502362. doi: 10.1016/j.gastrohep.2025.502362.
   PubMed         Abstract available
   
   

   
   Hepatology

2. CHEN PC, Deterding K, Engelskircher SA, Port K, et al
   TIGIT-expression on natural killer cell subsets is an early indicator of alleviating liver inflammation following bulevirtide treatment in chronic hepatitis D.
   Hepatology. 2025 Jan 23. doi: 10.1097/HEP.0000000000001238.
   PubMed         Abstract available
   
   
3. NISHITSUJI H, Naito Y, Murakami Y, Sugiyama M, et al
   Identification of glycogen synthase kinase 3alpha/beta as a host factor required for hepatitis B virus transcription using high-throughput screening.
   Hepatology. 2025 Jan 23. doi: 10.1097/HEP.0000000000001239.
   PubMed         Abstract available
   
   

   
   J Hepatol

4. SANDMANN L
   Antiviral treatment of chronic hepatitis D virus infection: To combine or not to combine?
   J Hepatol. 2025 Jan 20:S0168-8278(24)02820-4. doi: 10.1016/j.jhep.2024.
   PubMed        
   
   

   
   J Viral Hepat

5. FURQUIM D'ALMEIDA A, Ho E, Govaerts L, Michielsen P, et al
   Severe Liver-Related Outcomes in Patients With Hepatitis Delta: Results From a Multi-Ethnic Multicenter Long-Term Follow-Up Study.
   J Viral Hepat. 2025;32:1-15.
   PubMed         Abstract available
   
   
6. ONG E, Xia T, Laing R, Richmond JA, et al
   Australian Community Pharmacists' Preparedness to Offer and Discuss Hepatitis C Testing and Treatment With Pharmacy Clients: A Representative Cross-Sectional Survey.
   J Viral Hepat. 2025;32:e70001.
   PubMed         Abstract available
   
   
7. RAMRAKHIANI H, Le MH, Kam L, Nguyen B, et al
   Long-Term Immunity and Anamnestic Response Following Hepatitis B Vaccination: A Systematic Review and Meta-Analysis.
   J Viral Hepat. 2025;32:e70003.
   PubMed         Abstract available
   
   
8. UKAGEBU CJ, Alao JO, Bamigboye FO, Ukaegbu JC, et al
   Evaluating Hepatitis B Screening During Pregnancy: A Study on Diagnostic Accuracy and Infection Control in Nigeria.
   J Viral Hepat. 2025;32:e70002.
   PubMed         Abstract available
   
   

   
   J Virol

9. FEDORCHENKO SV, Klimenko Z, Martynovich T, Solianyk I, et al
   Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16-24 weeks.
   J Virol. 2025 Jan 22:e0184324. doi: 10.1128/jvi.01843.
   PubMed         Abstract available
   
   

   
   PLoS One

10. TOY M, Hutton D, Conners EE, Pham H, et al
    Cost-effectiveness of monitoring and liver cancer surveillance among patients with inactive chronic hepatitis B.
    PLoS One. 2025;20:e0313898.
    PubMed         Abstract available
    
    

    
    Virology

11. YAO X, Jia C, Li A, Qin T, et al
    Epidemiology and genotypic diversity of duck hepatitis B virus identified from waterfowl in partial areas of Guangdong province, Southern China.
    Virology. 2025;603:110416.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.